marimastat has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, W; Li, S; Lv, Y; Xiao, Q; Yin, L; Zhao, X; Zhu, L | 1 |
| Adam, MJ; auf dem Keller, U; Bellac, CL; Bénard, F; Dedhar, S; Harwig, C; Kappelhoff, R; Lange, PF; Li, Y; Lou, Y; Overall, CM; Perrin, DM; Ruth, TJ; Ting, R | 1 |
2 other study(ies) available for marimastat and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Targeting intracellular MMPs efficiently inhibits tumor metastasis and angiogenesis.
Topics: Angiogenesis Inhibitors; Animals; Caseins; Cell Line, Tumor; Drug Liberation; Female; Hyaluronic Acid; Hydroxamic Acids; Mammary Neoplasms, Experimental; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Mice; Mice, Inbred BALB C; Nanoconjugates; Neoplasm Metastasis; Neovascularization, Pathologic; Paclitaxel; Prodrugs; Protein Binding | 2018 |
Novel matrix metalloproteinase inhibitor [18F]marimastat-aryltrifluoroborate as a probe for in vivo positron emission tomography imaging in cancer.
Topics: Animals; Borates; Breast Neoplasms; Cell Line, Tumor; Enzyme Inhibitors; Female; Fluorine Radioisotopes; Humans; Hydroxamic Acids; Isoenzymes; Isotope Labeling; Mammary Neoplasms, Experimental; Matrix Metalloproteinase Inhibitors; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Radiopharmaceuticals | 2010 |